Stock 3320 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Delayed Hong Kong S.E.
Other stock markets
 11:51:04 2024-04-24 pm EDT 		5-day change 1st Jan Change
4.98 HKD +2.05% Intraday chart for China Resources Pharmaceutical Group Limited +5.97% -3.12%
Apr. 24 China Resources Pharmaceutical Group Limited Announces Change of Company Secretary CI
Apr. 18 China Resources Pharma Unit Issues 3 Billion Yuan Bonds MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Resources Pharmaceutical Group Limited Announces Change of Company Secretary
CI
China Resources Pharma Unit Issues 3 Billion Yuan Bonds
MT
China Resources Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Three Months Ended 31 March 2024
CI
China Resources Pharmaceutical Posts Gains in Full Year 2023 Profit
MT
China Resources Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024
CI
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue
MT
Nomura Adjusts CR Pharmaceutical Group’s Price Target to HK$8.80 From HK$9.08, Keeps at Buy
MT
CR Sanjiu Expects Increase in 2023 Profit
MT
China Resources Pharmaceutical Unit Completes Capital Increase; Shares Fall 3%
MT
China Resources Pharmaceutical Unit Enters Share Subscription Deals to Boost Capital
MT
China Resources Pharmaceutical Group Limited Announces Management Changes, Effective on 27 December 2023
CI
China Resources Pharma Unit Boosts Stake in Jiangzhong Pharma Parent
MT
China Resources Pharmaceutical Subsidiary Begins Bidding for Potential Share Issuance
MT
China Resources Pharmaceutical Group Subsidiary Records Rise in Nine-Month Attributable Profit
MT
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue
MT
CR Boya Bio-Pharmaceutical's January-September Profit Increases
MT
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%
MT
China Resources Pharma's Profit Marginally Rises in H1
MT
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3320 Stock
  4. News China Resources Pharmaceutical Group Limited